Global Biopharmaceutical Analytical Instrumentation Market, Forecast to 2022

Analytics Required for Biosimilar Drugs to Stimulate Market Growth

  • Research Code : K100-01-00-00-00
  • SKU : TM00430-GL-MR_19478
  • Share this :
  • Release Date : 03-Mar-2017
  • Region : Global
  • Request Study Sample

Availability: In stock

The global biopharmaceutical analytical instrumentation market generated a revenue of $1,092 million in 2015 and is expected to grow at a compound annual growth rate (CAGR) of 7.2% from 2015 to 2022.

The biosimilars segment, which is expected to reach $35 billion in 2025, will strongly drive the biopharmaceutical analytical instrumentation market. Strong analytical techniques will be used in the analysis of biosimilar drugs to improve product quality.

Emerging economies’ strong penetration into the global biosimilars segment will drive the need for analyzers. Key manufacturers are expanding their capabilities in these regions to bring advanced infrastructure to these markets.

Complex biopharmaceutical processes demand advanced method solutions. A combination of sensitive instruments, smart software, and advanced methods will lead to the successful deployment of practices.
USD 4,950

* Required Fields

Pay By Invoice

Be the first to review this product


1. Primary Research

Our analysis is based on comprehensive primary research conducted with core market participants.

2. Global Coverage

Unparalleled coverage of geographies, our analyst & consultant teams are based in 42+ offices spanning the globe.

3. Breadth of Vertical Industries

We cover the broadest spectrum of markets to provide our clients with the most relevant analysis and transformational insights.

4. Visionary Innovation Research

With on-going transformational shifts, our visionary innovation research prepares you with information on key megatrends shaping the future of your industry.

5. Mega Trends

Mega Trends are global forces that transform business, societies and economies.

6. Convergence Research Coverage

Taking an approach of analysing a macro-to-micro impact, our convergence research helps you prepare against an impending 'Kodak moment'.